<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-21163" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Enthesopathies</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Alvarez</surname>
            <given-names>Armando</given-names>
          </name>
          <aff>University of Miami/ Jackson Memorial Hospital</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Tiu</surname>
            <given-names>Timothy K.</given-names>
          </name>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Armando Alvarez declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Timothy Tiu declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>5</day>
          <month>6</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-21163.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Enthesopathies encompass a broad range of pathologies that include ligamentous and tendinous injuries. They are relatively common and can be the initial symptom of a more serious condition. To avoid the high morbidity associated with this condition, it must be promptly diagnosed and treated. This activity describes the evaluation, treatment, and management of enthesopathies, and reviews the role of the interprofessional team in the care of patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the etiology of enthesopathies.</p></list-item><list-item><p>Describe the appropriate evaluation of enthesopathies.</p></list-item><list-item><p>Outline the treatment and management options available for enthesopathies.</p></list-item><list-item><p>Summarize interprofessional team strategies for improving care coordination and communication to advance the care of enthesopathies and improve outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=21163&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=21163">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-21163.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Entheses are boney insertion sites of tendons and ligaments. Enthesopathies are defined as the pathologies that affect the entheses.<xref ref-type="bibr" rid="article-21163.r1">[1]</xref>&#x000a0;Although somewhat controversial, there appear to be two main classifications of entheses: 1) fibrous and 2) fibrocartilaginous. The difference is that fibrous entheses insert directly onto the periosteum, whereas fibrocartilaginous enthesis lack periosteum.<xref ref-type="bibr" rid="article-21163.r2">[2]</xref>&#x000a0;</p>
        <p>Anatomically, the entheses are usually found outside the joint capsule with exceptions, including the sacroiliac, sternoclavicular, and distal interphalangeal joints.<xref ref-type="bibr" rid="article-21163.r3">[3]</xref>&#x000a0;Entheses have two main roles: stability of the joint, and to transduce mechanical forces.<xref ref-type="bibr" rid="article-21163.r4">[4]</xref>&#x000a0;A unique aspect of the entheses is also the relative lack of vascularity.<xref ref-type="bibr" rid="article-21163.r2">[2]</xref>&#x000a0;Enthesitis, a subset of enthesopathy, is the inflammation of the insertion sites for the tendons and ligaments on the bone.<xref ref-type="bibr" rid="article-21163.r1">[1]</xref>&#x000a0;It is associated with diffuse inflammatory disorders such as psoriatic arthritis (PsA) and spondyloarthropathies (SpA).<xref ref-type="bibr" rid="article-21163.r4">[4]</xref></p>
      </sec>
      <sec id="article-21163.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Enthesopathies can be separated into two broad categories 1) repetitive mechanical stress and 2) diffuse inflammatory response. Enthesopathies from repetitive mechanical stress can be seen in common sports-related injuries such as lateral and medial&#x000a0;epicondylitis, and Achilles and shoulder enthesopathy. Diffuse inflammatory responses that lead to enthesopathies and enthesitis tend to affect multiple entheses. The repetitive local microtrauma allows innate immune cells to invade the local area and cause inflammation triggered by chemokines.<xref ref-type="bibr" rid="article-21163.r5">[5]</xref>&#x000a0;Chemokines involved in the local inflammatory response include CXCL1, CCL2, interleukin (IL)-17, tumor necrosis factor (TNF)-alpha, and prostaglandin E2 (PGE2).<xref ref-type="bibr" rid="article-21163.r3">[3]</xref><xref ref-type="bibr" rid="article-21163.r5">[5]</xref></p>
      </sec>
      <sec id="article-21163.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The prevalence and incidence of enthesopathies from a diffuse inflammatory disease are difficult to assess and calculate given the varied nature, presentation, and etiology of the enthesopathies.<xref ref-type="bibr" rid="article-21163.r6">[6]</xref>&#x000a0;It has been reported the prevalence of enthesitis in patients with PsA is approximately 35%.<xref ref-type="bibr" rid="article-21163.r7">[7]</xref>&#x000a0;In patients with SpA, 10&#x000a0;to 60% of patients that are diagnosed with SpA have enthesitis.<xref ref-type="bibr" rid="article-21163.r6">[6]</xref></p>
      </sec>
      <sec id="article-21163.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Enthesopathies can be due to a loss of fibrillar structure secondary to edema, mineralization, which leads to calcification and ossification, diffuse inflammatory disease, or altered structure of collagen fibers leading to a thickened enthesis.<xref ref-type="bibr" rid="article-21163.r1">[1]</xref>&#x000a0;Moreover, enthesopathies themselves can lead to other manifestations such as enthesophytes. Enthesophytes are due to new bone formation secondary to seronegative SpA, diabetes mellitus, local trauma, and calcium pyrophosphate deposition disease.<xref ref-type="bibr" rid="article-21163.r8">[8]</xref>&#x000a0;Oftentimes, mechanical stress is the inciting event that triggers the cascade and repetitive cycle of inflammation.<xref ref-type="bibr" rid="article-21163.r9">[9]</xref>&#x000a0;Common examples of mechanical stress enthesitis include lateral epicondylitis and medial epicondylitis of the elbow.</p>
        <p>Enthesitis is a common finding in both PsA and SpA. The key difference between enthesitis from mechanical stress and that from a diffuse inflammatory process such as PsA and SpA is that the diffuse inflammatory processes tend to affect multiple entheses. Mechanical stress, albeit theorized to be at a lower threshold, seems to be an inciting event in both localized enthesitis from repetitive stress and diffuse enthesitis from an inflammatory disease.<xref ref-type="bibr" rid="article-21163.r10">[10]</xref></p>
      </sec>
      <sec id="article-21163.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>The history and physical of enthesopathies depends on the location of the affected entheses. The patient may complain of decreased range of motion of the affected area as well as localized pain. Inspection may reveal localized swelling or erythema. Pain may be elicited by palpating the affected area as well as ranging the affected joint. Range of motion should be assessed both actively and passively for mechanical deficits and pain limitations.</p>
        <p>If a diffuse inflammatory disease is suspected, a more thorough physical exam should include the evaluation of commonly affected areas such as the sacroiliac joints, Achilles tendon, and distal interphalangeal joints. Moreover, asking a broad review of systems may reveal the underlying cause of enthesitis, such as weight loss, night sweats, chills, or any other constitutional symptoms.<xref ref-type="bibr" rid="article-21163.r4">[4]</xref></p>
      </sec>
      <sec id="article-21163.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The evaluation includes a thorough history and physical exam, depending on the underlying etiology of the enthesopathy. For enthesopathies secondary to repetitive use with a low likelihood of underlying inflammatory disease, the evaluation is primarily through physical examination, with imaging as needed. X-rays can be used to evaluate for bony pathology and calcifications. Diagnostic ultrasound or magnetic resonance imaging can be used to visualize soft tissue, including the enthesis itself.<xref ref-type="bibr" rid="article-21163.r4">[4]</xref></p>
        <p>Evaluation of enthesopathies secondary to a diffuse inflammatory response leading to enthesitis may include a complete blood count, HLA-B27 assessing for seronegative SpA, rheumatoid factor, anti-nuclear antibody, and other autoimmune factors that may reveal the underlying cause. Additionally, imaging studies may be ordered similar to those when evaluating enthesopathies from repetitive use.<xref ref-type="bibr" rid="article-21163.r3">[3]</xref></p>
      </sec>
      <sec id="article-21163.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Treatment depends on the underlying etiology. For an overuse enthesopathy, the mainstay of treatment is ice, rest, and nonsteroidal anti-inflammatory drugs (NSAIDs) for 7-10 days. <xref ref-type="bibr" rid="article-21163.r11">[11]</xref>&#x000a0;However, NSAID use is somewhat controversial in the acute period, as they may inhibit healing by blunting the inflammatory response.<xref ref-type="bibr" rid="article-21163.r11">[11]</xref><xref ref-type="bibr" rid="article-21163.r12">[12]</xref>&#x000a0;Adjunct therapies for enthesopathies also include skilled physical therapy, glucocorticoid injections, topical nitrate therapy, and platelet-rich plasma (PRP).</p>
        <p>Skilled physical therapy has been shown to improve pain, increase function, and increase active range of motion in a broad range of pathologies, which include shoulder, hip, elbow, and Achilles enthesopathy.<xref ref-type="bibr" rid="article-21163.r11">[11]</xref><xref ref-type="bibr" rid="article-21163.r13">[13]</xref><xref ref-type="bibr" rid="article-21163.r14">[14]</xref><xref ref-type="bibr" rid="article-21163.r15">[15]</xref>&#x000a0;From a biomechanics perspective, different joint position exercises may provide alternate stress on the tendon, which is theorized to stimulate healing after an injury.<xref ref-type="bibr" rid="article-21163.r16">[16]</xref></p>
        <p>Although routinely used in clinical practice, glucocorticoid injections are somewhat controversial. There is no clear evidence to support their use.<xref ref-type="bibr" rid="article-21163.r17">[17]</xref>&#x000a0;Moreover, glucocorticoids into the tendon are tenotoxic and may lead to further injury.<xref ref-type="bibr" rid="article-21163.r18">[18]</xref></p>
        <p>Topical nitrates are theorized to increase neovascularization, fibroblast activity, and promote collagen synthesis. Studies show promising results with topical glyceryl trinitrate (GTN) as being a good adjunct therapy for chronic tendinopathies such as wrist extensors, Achilles, patellar tendon, and rotator cuff. GTN comes in a patch form with dosages ranging from .72mg/day &#x02013; 5mg/day for tendinopathies.<xref ref-type="bibr" rid="article-21163.r19">[19]</xref></p>
        <p>PRP is proposed to have its effect via directly introducing a concentrate of growth factors, as well as establishing a rich microenvironment that recruits additional cells and growth factors to promote healing. Although still being researched, promising studies have shown that PRP may help in multiple enthesopathies such as gluteal tendinopathy and elbow tendinopathies.<xref ref-type="bibr" rid="article-21163.r20">[20]</xref><xref ref-type="bibr" rid="article-21163.r21">[21]</xref></p>
        <p>For calcific enthesopathies, a technique called barbotage can be used. Under direct visualization via ultrasound or fluoroscopy, a calcific lesion is repeatedly injected and aspirated, typically with saline. This has been shown to be effective in lateral epicondylopathy and rotator cuff calcific tendonitis.<xref ref-type="bibr" rid="article-21163.r22">[22]</xref><xref ref-type="bibr" rid="article-21163.r23">[23]</xref></p>
        <p>Enthesopathies caused by diffuse inflammatory diseases can be treated with disease-modifying antirheumatic drugs (DMARDs) such as methotrexate and hydroxychloroquine. Additionally, biologics such as rituximab, etanercept, and infliximab may be used to specifically act on inflammatory markers to help reduce the overall burden of disease.<xref ref-type="bibr" rid="article-21163.r24">[24]</xref></p>
      </sec>
      <sec id="article-21163.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnosis of enthesopathies can include avulsions, fractures, ligament or tendon rupture, localized infection, contusions, muscle strains, and malignancy.</p>
      </sec>
      <sec id="article-21163.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The prognosis of enthesopathies is generally favorable, given the underlying etiology. With adequate rest and rehabilitation, most cases of enthesopathies will resolve over 2-4 weeks.</p>
        <p>Enthesopathies from diffuse inflammatory disease may result in prolonged recovery times and is relative to the severity and etiology of the underlying disease.</p>
      </sec>
      <sec id="article-21163.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Tendon or ligament tear is a complication of both repetitive use and diffuse inflammatory disease enthesopathies.</p>
      </sec>
      <sec id="article-21163.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Multiple subspecialties may be presented with the initial presentation of enthesopathies, and an astute clinician will need to discern where the patient may need to be referred. Education for localized enthesopathies from repetitive use can be safely done in the clinician&#x02019;s office or with a skilled physical or occupational therapist. Educating on joint protective measures may also greatly benefit the patient with overuse enthesopathies.&#x000a0;For patients with an underlying systemic inflammatory disease, a more thorough and comprehensive educational approach may be necessary. Discussions with subspecialists such as physiatrists, rheumatologists, internal medicine, and immunologists may all be needed to adequately educate and treat select patients.</p>
      </sec>
      <sec id="article-21163.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>An interprofessional team approach provides the best outcome for patients with enthesopathies. Teamwork and coordination are quintessential in patients with enthesopathies from inflammatory diseases. Multiple sub-specialties are involved in the coordination of care, which includes primary care clinicians, physiatrists, rheumatologists, physical therapists, and occupational therapists. Such an approach allowed for comprehensive evaluation and treatment, especially in those suffering from spondyloarthropathy. [Level 2]<xref ref-type="bibr" rid="article-21163.r24">[24]</xref><xref ref-type="bibr" rid="article-21163.r25">[25]</xref></p>
      </sec>
      <sec id="article-21163.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=21163&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=21163">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/joint-muscle-and-bone/enthesopathies/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=21163">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/21163/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=21163">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-21163.s15">
        <title>References</title>
        <ref id="article-21163.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sudo&#x00142;-Szopi&#x00144;ska</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Kwiatkowska</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Prochorec-Sobieszek</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ma&#x0015b;li&#x00144;ski</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Enthesopathies and enthesitis. Part 1. Etiopathogenesis.</article-title>
            <source>J Ultrason</source>
            <year>2015</year>
            <month>Mar</month>
            <volume>15</volume>
            <issue>60</issue>
            <fpage>72</fpage>
            <page-range>72-84</page-range>
            <pub-id pub-id-type="pmid">26674568</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21163.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Benjamin</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Toumi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Ralphs</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Bydder</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Best</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Milz</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Where tendons and ligaments meet bone: attachment sites ('entheses') in relation to exercise and/or mechanical load.</article-title>
            <source>J Anat</source>
            <year>2006</year>
            <month>Apr</month>
            <volume>208</volume>
            <issue>4</issue>
            <fpage>471</fpage>
            <page-range>471-90</page-range>
            <pub-id pub-id-type="pmid">16637873</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21163.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Araujo</surname>
                <given-names>EG</given-names>
              </name>
              <name>
                <surname>Schett</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Enthesitis in psoriatic arthritis (Part 1): pathophysiology.</article-title>
            <source>Rheumatology (Oxford)</source>
            <year>2020</year>
            <month>Mar</month>
            <day>01</day>
            <volume>59</volume>
            <issue>Suppl 1</issue>
            <fpage>i10</fpage>
            <page-range>i10-i14</page-range>
            <pub-id pub-id-type="pmid">32159793</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21163.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schett</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Lories</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>D'Agostino</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Elewaut</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kirkham</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Soriano</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>McGonagle</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Enthesitis: from pathophysiology to treatment.</article-title>
            <source>Nat Rev Rheumatol</source>
            <year>2017</year>
            <month>Nov</month>
            <day>21</day>
            <volume>13</volume>
            <issue>12</issue>
            <fpage>731</fpage>
            <page-range>731-741</page-range>
            <pub-id pub-id-type="pmid">29158573</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21163.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cambr&#x000e9;</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Gaublomme</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Burssens</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Jacques</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Schryvers</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>De Muynck</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Meuris</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Lambrecht</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Carter</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>de Bleser</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Saeys</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Van Hoorebeke</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Kollias</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Mack</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Simoens</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Lories</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Callewaert</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Schett</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Elewaut</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Mechanical strain determines the site-specific localization of inflammation and tissue damage in arthritis.</article-title>
            <source>Nat Commun</source>
            <year>2018</year>
            <month>Nov</month>
            <day>05</day>
            <volume>9</volume>
            <issue>1</issue>
            <fpage>4613</fpage>
            <pub-id pub-id-type="pmid">30397205</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21163.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Braun</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Khan</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Sieper</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Enthesitis and ankylosis in spondyloarthropathy: what is the target of the immune response?</article-title>
            <source>Ann Rheum Dis</source>
            <year>2000</year>
            <month>Dec</month>
            <volume>59</volume>
            <issue>12</issue>
            <fpage>985</fpage>
            <page-range>985-94</page-range>
            <pub-id pub-id-type="pmid">11087703</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21163.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Polachek</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chandran</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Gladman</surname>
                <given-names>DD</given-names>
              </name>
            </person-group>
            <article-title>Clinical Enthesitis in a Prospective Longitudinal Psoriatic Arthritis Cohort: Incidence, Prevalence, Characteristics, and Outcome.</article-title>
            <source>Arthritis Care Res (Hoboken)</source>
            <year>2017</year>
            <month>Nov</month>
            <volume>69</volume>
            <issue>11</issue>
            <fpage>1685</fpage>
            <page-range>1685-1691</page-range>
            <pub-id pub-id-type="pmid">27998023</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21163.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hardcastle</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Dieppe</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Gregson</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Arden</surname>
                <given-names>NK</given-names>
              </name>
              <name>
                <surname>Spector</surname>
                <given-names>TD</given-names>
              </name>
              <name>
                <surname>Hart</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Edwards</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Dennison</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Cooper</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Davey Smith</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Tobias</surname>
                <given-names>JH</given-names>
              </name>
            </person-group>
            <article-title>Osteophytes, enthesophytes, and high bone mass: a bone-forming triad with potential relevance in osteoarthritis.</article-title>
            <source>Arthritis Rheumatol</source>
            <year>2014</year>
            <month>Sep</month>
            <volume>66</volume>
            <issue>9</issue>
            <fpage>2429</fpage>
            <page-range>2429-39</page-range>
            <pub-id pub-id-type="pmid">24910132</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21163.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jacques</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Lambrecht</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Verheugen</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Pauwels</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Kollias</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Armaka</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Verhoye</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Van der Linden</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Achten</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lories</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Elewaut</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Proof of concept: enthesitis and new bone formation in spondyloarthritis are driven by mechanical strain and stromal cells.</article-title>
            <source>Ann Rheum Dis</source>
            <year>2014</year>
            <month>Feb</month>
            <volume>73</volume>
            <issue>2</issue>
            <fpage>437</fpage>
            <page-range>437-45</page-range>
            <pub-id pub-id-type="pmid">23921997</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21163.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Benjamin</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>McGonagle</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>The anatomical basis for disease localisation in seronegative spondyloarthropathy at entheses and related sites.</article-title>
            <source>J Anat</source>
            <year>2001</year>
            <month>Nov</month>
            <volume>199</volume>
            <issue>Pt 5</issue>
            <fpage>503</fpage>
            <page-range>503-26</page-range>
            <pub-id pub-id-type="pmid">11760883</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21163.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Steuri</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sattelmayer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Elsig</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kolly</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Tal</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Taeymans</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hilfiker</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Effectiveness of conservative interventions including exercise, manual therapy and medical management in adults with shoulder impingement: a systematic review and meta-analysis of RCTs.</article-title>
            <source>Br J Sports Med</source>
            <year>2017</year>
            <month>Sep</month>
            <volume>51</volume>
            <issue>18</issue>
            <fpage>1340</fpage>
            <page-range>1340-1347</page-range>
            <pub-id pub-id-type="pmid">28630217</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21163.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rees</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Wolman</surname>
                <given-names>RL</given-names>
              </name>
            </person-group>
            <article-title>Current concepts in the management of tendon disorders.</article-title>
            <source>Rheumatology (Oxford)</source>
            <year>2006</year>
            <month>May</month>
            <volume>45</volume>
            <issue>5</issue>
            <fpage>508</fpage>
            <page-range>508-21</page-range>
            <pub-id pub-id-type="pmid">16490749</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21163.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Frizziero</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Vittadini</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Pignataro</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gasparre</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Biz</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ruggieri</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Masiero</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Conservative management of tendinopathies around hip.</article-title>
            <source>Muscles Ligaments Tendons J</source>
            <year>2016</year>
            <season>Jul-Sep</season>
            <volume>6</volume>
            <issue>3</issue>
            <fpage>281</fpage>
            <page-range>281-292</page-range>
            <pub-id pub-id-type="pmid">28066732</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21163.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Smidt</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>van der Windt</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Assendelft</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Devill&#x000e9;</surname>
                <given-names>WL</given-names>
              </name>
              <name>
                <surname>Korthals-de Bos</surname>
                <given-names>IB</given-names>
              </name>
              <name>
                <surname>Bouter</surname>
                <given-names>LM</given-names>
              </name>
            </person-group>
            <article-title>Corticosteroid injections, physiotherapy, or a wait-and-see policy for lateral epicondylitis: a randomised controlled trial.</article-title>
            <source>Lancet</source>
            <year>2002</year>
            <month>Feb</month>
            <day>23</day>
            <volume>359</volume>
            <issue>9307</issue>
            <fpage>657</fpage>
            <page-range>657-62</page-range>
            <pub-id pub-id-type="pmid">11879861</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21163.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sussmilch-Leitch</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Collins</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Bialocerkowski</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Warden</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Crossley</surname>
                <given-names>KM</given-names>
              </name>
            </person-group>
            <article-title>Physical therapies for Achilles tendinopathy: systematic review and meta-analysis.</article-title>
            <source>J Foot Ankle Res</source>
            <year>2012</year>
            <month>Jul</month>
            <day>02</day>
            <volume>5</volume>
            <issue>1</issue>
            <fpage>15</fpage>
            <pub-id pub-id-type="pmid">22747701</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21163.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maganaris</surname>
                <given-names>CN</given-names>
              </name>
              <name>
                <surname>Narici</surname>
                <given-names>MV</given-names>
              </name>
              <name>
                <surname>Almekinders</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Maffulli</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Biomechanics and pathophysiology of overuse tendon injuries: ideas on insertional tendinopathy.</article-title>
            <source>Sports Med</source>
            <year>2004</year>
            <volume>34</volume>
            <issue>14</issue>
            <fpage>1005</fpage>
            <page-range>1005-17</page-range>
            <pub-id pub-id-type="pmid">15571430</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21163.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Speed</surname>
                <given-names>CA</given-names>
              </name>
            </person-group>
            <article-title>Fortnightly review: Corticosteroid injections in tendon lesions.</article-title>
            <source>BMJ</source>
            <year>2001</year>
            <month>Aug</month>
            <day>18</day>
            <volume>323</volume>
            <issue>7309</issue>
            <fpage>382</fpage>
            <page-range>382-6</page-range>
            <pub-id pub-id-type="pmid">11509432</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21163.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fredberg</surname>
                <given-names>U</given-names>
              </name>
            </person-group>
            <article-title>Local corticosteroid injection in sport: review of literature and guidelines for treatment.</article-title>
            <source>Scand J Med Sci Sports</source>
            <year>1997</year>
            <month>Jun</month>
            <volume>7</volume>
            <issue>3</issue>
            <fpage>131</fpage>
            <page-range>131-9</page-range>
            <pub-id pub-id-type="pmid">9200316</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21163.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Challoumas</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kirwan</surname>
                <given-names>PD</given-names>
              </name>
              <name>
                <surname>Borysov</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Clifford</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>McLean</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Millar</surname>
                <given-names>NL</given-names>
              </name>
            </person-group>
            <article-title>Topical glyceryl trinitrate for the treatment of tendinopathies: a systematic review.</article-title>
            <source>Br J Sports Med</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>53</volume>
            <issue>4</issue>
            <fpage>251</fpage>
            <page-range>251-262</page-range>
            <pub-id pub-id-type="pmid">30301735</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21163.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Harrison</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Boachie-Adjei</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Vargas</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Moley</surname>
                <given-names>PJ</given-names>
              </name>
            </person-group>
            <article-title>Platelet-Rich Plasma Injections With Needle Tenotomy for Gluteus Medius Tendinopathy: A Registry Study With Prospective Follow-up.</article-title>
            <source>Orthop J Sports Med</source>
            <year>2016</year>
            <month>Nov</month>
            <volume>4</volume>
            <issue>11</issue>
            <fpage>2325967116671692</fpage>
            <pub-id pub-id-type="pmid">27868077</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21163.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kwapisz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Prabhakar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Compagnoni</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sibilska</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Randelli</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Platelet-Rich Plasma for Elbow Pathologies: a Descriptive Review of Current Literature.</article-title>
            <source>Curr Rev Musculoskelet Med</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>11</volume>
            <issue>4</issue>
            <fpage>598</fpage>
            <page-range>598-606</page-range>
            <pub-id pub-id-type="pmid">30255288</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21163.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Abate</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Salini</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Schiavone</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Ultrasound-guided Percutaneous Lavage in the Treatment of Calcific Tendinopathy of Elbow Extensor Tendons: A Case Report.</article-title>
            <source>Malays Orthop J</source>
            <year>2016</year>
            <month>Jul</month>
            <volume>10</volume>
            <issue>2</issue>
            <fpage>53</fpage>
            <page-range>53-55</page-range>
            <pub-id pub-id-type="pmid">28435563</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21163.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Burke</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Adler</surname>
                <given-names>RS</given-names>
              </name>
            </person-group>
            <article-title>Ultrasound-Guided Percutaneous Tendon Treatments.</article-title>
            <source>AJR Am J Roentgenol</source>
            <year>2016</year>
            <month>Sep</month>
            <volume>207</volume>
            <issue>3</issue>
            <fpage>495</fpage>
            <page-range>495-506</page-range>
            <pub-id pub-id-type="pmid">27224839</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21163.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rizzello</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Olivieri</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Armuzzi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ayala</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Bettoli</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Bianchi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Cimino</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Costanzo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cristaudo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>D'Angelo</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Daperno</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Fostini</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Galeazzi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gilio</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gionchetti</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Gisondi</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Lubrano</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Marchesoni</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Offidani</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Orlando</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pugliese</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Salvarani</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Scarpa</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Vecchi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Girolomoni</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Multidisciplinary Management of Spondyloarthritis-Related Immune-Mediated Inflammatory Disease.</article-title>
            <source>Adv Ther</source>
            <year>2018</year>
            <month>Apr</month>
            <volume>35</volume>
            <issue>4</issue>
            <fpage>545</fpage>
            <page-range>545-562</page-range>
            <pub-id pub-id-type="pmid">29516409</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21163.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Armuzzi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Felice</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lubrano</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Cantini</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Castiglione</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Gionchetti</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Orlando</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Salvarani</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Scarpa</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Marchesoni</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Vecchi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Olivieri</surname>
                <given-names>I</given-names>
              </name>
              <collab>Italian SpA-IBD Expert Panel Group</collab>
            </person-group>
            <article-title>Multidisciplinary management of patients with coexisting inflammatory bowel disease and spondyloarthritis: A Delphi consensus among Italian experts.</article-title>
            <source>Dig Liver Dis</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>49</volume>
            <issue>12</issue>
            <fpage>1298</fpage>
            <page-range>1298-1305</page-range>
            <pub-id pub-id-type="pmid">28822731</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
